Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer
Open Access
- 15 April 2001
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 84 (8) , 1016-1022
- https://doi.org/10.1054/bjoc.2000.1711
Abstract
Results of the proton magnetic resonance spectroscopy carried out on normal, benign breast disease and locally advanced breast cancer patients are presented. The in-vivo MR spectra of malignant breast tissue of patients (n = 67) suffering from infiltrating ductal carcinoma are dominated by the water resonance, while the spectra of the unaffected contralateral breast tissue of these patients are mainly dominated by resonance arising from lipids which is similar to the spectra of normal breast tissue obtained from volunteers (controls, n = 16). In addition to the water and lipid peaks, in majority of the patients (approximately 80%) the water suppressed spectra showed a resonance at 3.2 ppm due to choline containing compounds (TCho) before treatment. In patients receiving neoadjuvant chemotherapy, absence/reduction in choline was observed in 89% of the patients. TCho was also observed in 2 of 14 benign lesions. The sensitivity and specificity of in-vivo MRS in detecting TCho in malignant tumours was 78% and 86%, respectively. Observation of TCho before treatment and its disappearance (or reduction) after treatment may be a useful indicator of response of locally advanced breast cancer to neoadjuvant chemotherapy.Keywords
This publication has 26 references indexed in Scilit:
- Human breast lesions: characterization with proton MR spectroscopy.Radiology, 1998
- High-resolution MR imaging for the detection, diagnosis, and staging of breast cancer.RadioGraphics, 1998
- MRI of the breast: state of the artEuropean Radiology, 1998
- Contrast-enhanced breast MRI: factors affecting sensitivity and specificityEuropean Radiology, 1997
- Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy.Radiology, 1997
- Diagnostic Accuracy of Mammography and Contrast-Enhanced MR Imaging in 238 Histologically Verified Breast LesionsActa Radiologica, 1997
- Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutionsEuropean Journal of Radiology, 1997
- High-resolution MR imaging of the breast: clinical context.RadioGraphics, 1996
- IN-VIVO 31P MAGNETIC RESONANCE SPECTROSCOPY FOR MONITORING TREATMENT RESPONSE IN BREAST CANCERThe Lancet, 1989
- Human breast cancer in vivo: H-1 and P-31 MR spectroscopy at 1.5 T.Radiology, 1988